- Home
- BDN vs ORGO Comparison
BDN vs ORGO Comparison
Compare BDN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDN
- ORGO
- Stock Information
- Founded
- BDN 1986
- ORGO 1985
- Country
- BDN United States
- ORGO United States
- Employees
- BDN N/A
- ORGO N/A
- Industry
- BDN Real Estate Investment Trusts
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- BDN Real Estate
- ORGO Health Care
- Exchange
- BDN Nasdaq
- ORGO Nasdaq
- Market Cap
- BDN 799.6M
- ORGO 665.8M
- IPO Year
- BDN N/A
- ORGO N/A
- Fundamental
- Price
- BDN $3.97
- ORGO $4.45
- Analyst Decision
- BDN Hold
- ORGO Buy
- Analyst Count
- BDN 1
- ORGO 2
- Target Price
- BDN $5.00
- ORGO $5.50
- AVG Volume (30 Days)
- BDN 2.9M
- ORGO 1.4M
- Earning Date
- BDN 04-22-2025
- ORGO 05-08-2025
- Dividend Yield
- BDN 15.31%
- ORGO N/A
- EPS Growth
- BDN N/A
- ORGO N/A
- EPS
- BDN N/A
- ORGO N/A
- Revenue
- BDN $313,998,000.00
- ORGO $482,043,000.00
- Revenue This Year
- BDN $57.03
- ORGO $3.31
- Revenue Next Year
- BDN $3.55
- ORGO $12.50
- P/E Ratio
- BDN N/A
- ORGO N/A
- Revenue Growth
- BDN N/A
- ORGO 11.29
- 52 Week Low
- BDN $3.41
- ORGO $2.17
- 52 Week High
- BDN $6.54
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- BDN 45.27
- ORGO 52.57
- Support Level
- BDN $3.69
- ORGO $4.11
- Resistance Level
- BDN $3.84
- ORGO $4.38
- Average True Range (ATR)
- BDN 0.25
- ORGO 0.35
- MACD
- BDN 0.04
- ORGO 0.03
- Stochastic Oscillator
- BDN 69.14
- ORGO 80.17
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.